Medications

Clinical trials for first-ever human hookworm vaccine advance

The Sabin Vaccine Institute (Sabin) today announced the start of Part II of its Phase I clinical trial of the Na-GST-1 vaccine candidate, marking another major milestone in the progress toward developing a human hookworm ...

Medical research

New framework for more effective vaccine vectors

Despite the development of new technologies for successful vaccination against contagious diseases and cancer, there is a lack of standard operation procedures (SOPs) and cross-comparison. European scientists built the framework ...

Diseases, Conditions, Syndromes

Scientists make dengue vaccine breakthrough

Dengue is one of the most widespread mosquito-borne viral diseases in the world, with WHO estimating that around half of the world's population are currently at risk. While infection usually causes flu-like symptoms, it can ...

Medications

CDC preparing vaccine for new swine flu

(HealthDay) -- Only 29 human cases of a new strain of "swine" flu have been identified in two years, but the U.S. Centers for Disease Control and Prevention is making sure it's prepared should the H3N2 strain become more ...

Medications

Progress reported with candidate dengue vaccine

Trials in Thailand with a candidate vaccine for dengue, a potentially fatal mosquito-borne disease, have shown it to protect against three of the four virus strains, its French maker said Wednesday.

Medications

Researchers say step closer to meningitis B vaccine

Researchers said Monday they were a step closer to developing a vaccine against the type of meningitis that mostly affects Europe and North America and kills hundreds every year.

Medications

Tuberculosis vaccine being tested in Phase II trial

The only tuberculosis vaccine currently available is already over 90 years old - and is unsatisfactory in terms of its effectiveness. Although it protects young children against developing tuberculosis, it quickly loses its ...

page 38 from 40